HTG Molecular Diagnostics, Inc. (HTGMQ)

Market Cap	221.00 -100.0%
Revenue (ttm)	6.21M -28.2%
Net Income	-20.15M
EPS	-15.79
Shares Out	2.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,632
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	-110.52
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company dist...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 54
• Stock Exchange: OTCMKTS
• Ticker Symbol: HTGMQ